# Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF).

> **NCT00335894** · PHASE3 · COMPLETED · sponsor: **IBSA Institut Biochimique SA** · enrollment: 144 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** hMG-IBSA

## Key facts

- **NCT ID:** NCT00335894
- **Lead sponsor:** IBSA Institut Biochimique SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-05
- **Final completion:** 2009-03
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2010-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00335894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00335894, "Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF).". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00335894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*